Covered recipient · General Payments record
PAUL A FALLON
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$655.58
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $207.39 | 17 |
| Education | $27.27 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lundbeck LLC | $160.59 | 15 |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 1 |
| Teva Pharmaceuticals USA, Inc. | $24.37 | 1 |
| ABBVIE INC. | $22.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.43 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103707923 | CMS |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 11/19/2024 | Education | Undisputed | 01/23/2026 | 1101633567 | CMS |
| Lundbeck LLC | $21.09 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914467 | CMS |
| Lundbeck LLC | $0.34 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914469 | CMS |
| Lundbeck LLC | $23.31 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914471 | CMS |
| Lundbeck LLC | $0.20 | 03/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914473 | CMS |
| Lundbeck LLC | $28.60 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914475 | CMS |
| Lundbeck LLC | $0.43 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914477 | CMS |
| Lundbeck LLC | $20.38 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914479 | CMS |
| Lundbeck LLC | $0.53 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914481 | CMS |
| Lundbeck LLC | $4.14 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914483 | CMS |
| Lundbeck LLC | $7.62 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914485 | CMS |
| Lundbeck LLC | $23.57 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914487 | CMS |
| Lundbeck LLC | $1.00 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914489 | CMS |
| Lundbeck LLC | $1.78 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914491 | CMS |
| Lundbeck LLC | $27.07 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914493 | CMS |
| Lundbeck LLC | $0.53 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914495 | CMS |
| Teva Pharmaceuticals USA, Inc. | $24.37 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151591511 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.